199 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
rights. The employer or the employee may disclose such inventions to the department of employment security, and the department shall maintain a record of such disclosures for a minimum period of five years.
iv
8-K
INVA
Innoviva Inc
7 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:42pm
Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to Dr. Deborah L. Birx’s previously disclosed
SC TO-T
EX-99
fzzmq ivsd
25 Jul 22
Third party tender offer statement
8:34am
SC TO-T
EX-99
qdsp qlhrtmr
25 Jul 22
Third party tender offer statement
8:34am
8-K
EX-10.1
oitm juc7w4dfwrj
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm
SC TO-C
EX-2.1
3mn ry2r57dv2w
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-2.1
5lz9rll
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
9cbzmfd8jee6 lu
11 Jul 22
Business combination disclosure
7:38am
SC TO-T
EX-99
frqd ceij
7 Jun 22
Third party tender offer statement
9:04am
SC TO-C
EX-2.1
vb6 kkuwvmvlf3e1
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
9tqcz3eb pt5
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-4.1
7hi6xp3bgc1prc5
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm
8-K
EX-10.1
f43psk
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm